Ufp Technologies (UFPT) Capital Expenditures Growth (3y) (2013 - 2026)
Ufp Technologies (UFPT) Capital Expenditures Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 10.17% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 1.81% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.15% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 0.84% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.35% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 8.08% |
| 10 | Ufp Technologies | 1.85 Bn | 1.83 Bn | 44.36 Mn | -7.12% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.12% |
| Sep 30, 2025 | -64.51% |
| Jun 30, 2025 | -22.63% |
| Mar 31, 2025 | 6.47% |
| Dec 31, 2024 | -71.82% |
| Sep 30, 2024 | 29.20% |
| Jun 30, 2024 | 14.77% |
| Mar 31, 2024 | 6.13% |
| Dec 31, 2023 | 28.10% |
| Sep 30, 2023 | 45.37% |
| Jun 30, 2023 | 34.83% |
| Mar 31, 2023 | 28.79% |
| Dec 31, 2022 | 28.50% |
| Sep 30, 2022 | 14.00% |
| Jun 30, 2022 | 62.74% |
| Mar 31, 2022 | 18.92% |
| Dec 31, 2021 | 7.22% |
| Sep 30, 2021 | -13.36% |
| Jun 30, 2021 | 6.98% |
| Mar 31, 2021 | -1.01% |